Trials / Terminated
TerminatedNCT03916068
Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy
A Pilot Study Comparing Acute Post-Radiation Hyperbaric Oxygen (HBO2) Versus Trental and Vitamin E for Breast Cancer Patients Who Have Recently Completed Radiation Therapy as Part of Their Treatment Course
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Legacy Health System · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare patients that receive hyperbaric oxygen or Trental and Vitamin E immediately after completion of radiation therapy to evaluate which treatment best reduces radiation fibrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hyperbaric Oxygen Therapy | Hyperbaric oxygen therapy at 2.4 atmospheres for 90 minutes for 30 sessions. |
| DRUG | Trental Pill | Trental 400 mg three times daily, in combination with Vitamin E 400 IU twice daily |
| DIETARY_SUPPLEMENT | Vitamin E | Vitamin E 400 IU twice daily, in combination with Trental 400 mg three times daily |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2023-10-02
- Completion
- 2023-10-02
- First posted
- 2019-04-16
- Last updated
- 2023-10-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03916068. Inclusion in this directory is not an endorsement.